Skip to content

Clinical trials

Terminated Small Cell Lung Carcinoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Terminated Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20101
20112
20121
20131
20141
20151
20173
20193
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
AbbVie1
Alaunos Therapeutics1
BioNTech SE1
Cambridge University Hospitals NHS Foundation Trust1
Cancer Research UK1
EMD Serono Research & Development Institute, Inc.1
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.1
ImmunoGen, Inc.1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma18
Carcinoma, Non-Small-Cell Lung6
Melanoma4
Squamous Cell Carcinoma of Head and Neck4
Breast Neoplasms3
Carcinoma, Renal Cell3
Esophageal Squamous Cell Carcinoma3
Ovarian Neoplasms3
Stomach Neoplasms3
Anus Neoplasms2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.